Log In
Print
BCIQ
Print
Print this Print this
 

MVA-MUC1-IL2 (TG 4010, TG4010)

  Manage Alerts
Collapse Summary General Information
Company Transgene S.A.
DescriptionModified vaccinia Ankara (MVA) vector containing the mucin 1 (MUC1; CD227) and interleukin-2 (IL-2) genes
Molecular Target Not applicable
Mechanism of ActionVaccine
Latest Stage of DevelopmentPhase II
IndicationNon-small cell lung cancer (NSCLC)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today